Comparison Between Efficacy of Topical Tranexamic Acid Vs Topical Ethyl Ascorbic Acid In Treatment Of Melasma

ConditionMelasma

Trial statusNot yet recruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18-50

SponsorHayatabad Medical Complex

About this trial

This study is to compare the efficacy of topical tranexamic acid vs topical ethyl ascorbic acid in the treatment of melasma

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults age 18 to 50 years Clinically diagnosed Melasma Irrespective of gender and ethnicity

Disqualifiers

pregnant and lactating women Patients with a history of skin allergies to study medications Use of systemic steroides or anti coagulants within the last month Patients on other melasma treatments for atleast 4 weeks prior

Trial design

Design model

Parallel

Treatments tested in this trial

Ethyl ascorbic acid topical application
Drug
The participants in this arm of study will only receive topical ethyl ascorbic acid once daily at night for 12 weeks
Tranxemic acid topical application
Drug
The participants in this arm will receive only topical tranexamic acid once daily for 12 weeks

Treatment groups

128 Participants

are divided into 2 treatment groups

Group A: ethyl ascorbic acid GroupActive comparator 2 interventions

Group B: Topical tranexamic acid groupActive comparator 2 interventions

Trial outcomes

Primary outcomes

Assessment of Melasma Area Index Score

We will assist the improvement in hyperpigmented patches of melasma based on MASI

Time frame

6 months

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Hayatabad Medical Complex

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: